CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid - In Capital	Accumulated Deficit	Cumulative Translation Adjustment
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2021		4,086,534
Stockholders' equity, beginning balance at Dec. 31, 2021	$ 212,423	$ 0	$ 281,819	$ (69,396)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	362		362
Issuance of shares, net of issuance costs (in shares)		41,500
Issuance of shares, net of issuance costs	3,791		3,791
Restricted shares award issuance, net of withholdings (in shares)		8,260
Restricted shares award issuance, net of withholdings	(65)		(65)
Proceeds from stock options exercised (in shares)		33
Proceeds from stock options exercised	2		2
Foreign currency translation adjustment	(32)				(32)
Net loss	(429)			(429)
Stockholders' equity ending balance (in shares) at Mar. 31, 2022		4,136,327
Stockholders equity, ending balance at Mar. 31, 2022	216,052	$ 0	285,909	(69,825)	(32)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	306		306
Issuance of shares, net of issuance costs (in shares)		55,359
Issuance of shares, net of issuance costs	2,078		2,078
Proceeds from stock options exercised (in shares)		196
Proceeds from stock options exercised	12		12
Foreign currency translation adjustment	(134)				(134)
Net loss	(107,882)			(107,882)
Stockholders' equity ending balance (in shares) at Jun. 30, 2022		4,191,882
Stockholders equity, ending balance at Jun. 30, 2022	110,432	$ 0	288,305	(177,707)	(166)
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2022		4,625,278
Stockholders' equity, beginning balance at Dec. 31, 2022	(47,047)	$ 0	293,774	(340,464)	(357)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	481		481
Issuance of shares, net of issuance costs (in shares)		1,211,926
Issuance of shares, net of issuance costs	$ 8,096	$ 1	8,095
Restricted shares award issuance, net of withholdings (in shares)		9,275
Issuance of shares for amendment fee associated with debt modification (Note 9), net of issuance costs (in shares)	133,333
Issuance of shares for amendment fee associated with debt modification (Note 9), net of issuance costs	$ 1,000		1,000
Foreign currency translation adjustment	17				17
Net loss	(8,171)			(8,171)
Stockholders' equity ending balance (in shares) at Mar. 31, 2023		5,979,812
Stockholders equity, ending balance at Mar. 31, 2023	(45,624)	$ 1	303,350	(348,635)	(340)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	568		568
Issuance of shares, net of issuance costs (in shares)		1,253,434
Issuance of shares, net of issuance costs	3,320		3,320
Restricted shares award issuance, net of withholdings (in shares)		3,368
Foreign currency translation adjustment	10				10
Net loss	(10,042)			(10,042)
Stockholders' equity ending balance (in shares) at Jun. 30, 2023		7,236,614
Stockholders equity, ending balance at Jun. 30, 2023	$ (51,768)	$ 1	$ 307,238	$ (358,677)	$ (330)